Phase 1/2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Age-Related Macular Degeneration

NCT00712491 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Age-related Macular Degeneration
Choroidal Neovascularization

Interventions

DRUG: Sirolimus
DRUG: Sirolimus

Sponsor

Santen Inc.

Collaborators

[object Object]